EAC evaluation | College Learning Connection

Objectives

Speaker met learning objectives *

Please evaluate the speakers for those sessions you attended. NOTE: You MUST click N/A if you did not attend a session

	N/A	Poor	Fair	Good	Excellent
David Lang, MD: Severe asthma: Epidemiology and burden of illness	David Lang, MD: Severe asthma: Epidemiology and burden of illness - N/A	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Poor	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Fair	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Good	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Excellent
Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - N/A	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Poor	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Fair	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Good	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Excellent
Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - N/A	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Poor	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Fair	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Good	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Excellent
Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD)	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - N/A	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Poor	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Fair	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Good	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Excellent
David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - N/A	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Poor	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Fair	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Good	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Excellent
Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - N/A	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Poor	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Fair	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Good	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Excellent
John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - N/A	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Poor	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Fair	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Good	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Excellent
Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - N/A	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Poor	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Fair	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Good	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Excellent
Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - N/A	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Poor	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Fair	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Good	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Excellent
Alena Banerji, MD: Utility of skin testing in drug allergy	Alena Banerji, MD: Utility of skin testing in drug allergy - N/A	Alena Banerji, MD: Utility of skin testing in drug allergy - Poor	Alena Banerji, MD: Utility of skin testing in drug allergy - Fair	Alena Banerji, MD: Utility of skin testing in drug allergy - Good	Alena Banerji, MD: Utility of skin testing in drug allergy - Excellent
David Khan, MD: Drug induced skin eruptions	David Khan, MD: Drug induced skin eruptions - N/A	David Khan, MD: Drug induced skin eruptions - Poor	David Khan, MD: Drug induced skin eruptions - Fair	David Khan, MD: Drug induced skin eruptions - Good	David Khan, MD: Drug induced skin eruptions - Excellent
Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - N/A	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Poor	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Fair	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Good	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Excellent
Rey Panettieri, MD: Improving COPD outcomes	Rey Panettieri, MD: Improving COPD outcomes - N/A	Rey Panettieri, MD: Improving COPD outcomes - Poor	Rey Panettieri, MD: Improving COPD outcomes - Fair	Rey Panettieri, MD: Improving COPD outcomes - Good	Rey Panettieri, MD: Improving COPD outcomes - Excellent
Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - N/A	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Poor	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Fair	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Good	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Excellent
Leonard Bacharier, MD: Severe asthma in children	Leonard Bacharier, MD: Severe asthma in children - N/A	Leonard Bacharier, MD: Severe asthma in children - Poor	Leonard Bacharier, MD: Severe asthma in children - Fair	Leonard Bacharier, MD: Severe asthma in children - Good	Leonard Bacharier, MD: Severe asthma in children - Excellent
David Skoner, MD: Update on corticosteroid safety in children	David Skoner, MD: Update on corticosteroid safety in children - N/A	David Skoner, MD: Update on corticosteroid safety in children - Poor	David Skoner, MD: Update on corticosteroid safety in children - Fair	David Skoner, MD: Update on corticosteroid safety in children - Good	David Skoner, MD: Update on corticosteroid safety in children - Excellent
Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - N/A	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Poor	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Fair	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Good	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Excellent
Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - N/A	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Poor	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Fair	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Good	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Excellent
Matt Greenhawt, MD: Food allergy and quality of life	Matt Greenhawt, MD: Food allergy and quality of life - N/A	Matt Greenhawt, MD: Food allergy and quality of life - Poor	Matt Greenhawt, MD: Food allergy and quality of life - Fair	Matt Greenhawt, MD: Food allergy and quality of life - Good	Matt Greenhawt, MD: Food allergy and quality of life - Excellent
David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - N/A	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Poor	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Fair	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Good	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Excellent
Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - N/A	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Poor	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Fair	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Good	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Excellent
David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - N/A	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Poor	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Fair	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Good	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Excellent

Content

Speaker provided high quality educational content *

Please rate the speakers. NOTE: You MUST click N/A if you did not attend a session.

	N/A	Poor	Fair	Good	Excellent
David Lang, MD: Severe asthma: Epidemiology and burden of illness	David Lang, MD: Severe asthma: Epidemiology and burden of illness - N/A	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Poor	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Fair	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Good	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Excellent
Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - N/A	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Poor	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Fair	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Good	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Excellent
Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - N/A	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Poor	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Fair	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Good	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Excellent
Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD)	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - N/A	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Poor	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Fair	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Good	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Excellent
David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - N/A	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Poor	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Fair	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Good	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Excellent
Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - N/A	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Poor	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Fair	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Good	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Excellent
John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - N/A	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Poor	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Fair	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Good	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Excellent
Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - N/A	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Poor	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Fair	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Good	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Excellent
Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - N/A	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Poor	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Fair	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Good	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Excellent
Alena Banerji, MD: Utility of skin testing in drug allergy	Alena Banerji, MD: Utility of skin testing in drug allergy - N/A	Alena Banerji, MD: Utility of skin testing in drug allergy - Poor	Alena Banerji, MD: Utility of skin testing in drug allergy - Fair	Alena Banerji, MD: Utility of skin testing in drug allergy - Good	Alena Banerji, MD: Utility of skin testing in drug allergy - Excellent
David Khan, MD: Drug induced skin eruptions	David Khan, MD: Drug induced skin eruptions - N/A	David Khan, MD: Drug induced skin eruptions - Poor	David Khan, MD: Drug induced skin eruptions - Fair	David Khan, MD: Drug induced skin eruptions - Good	David Khan, MD: Drug induced skin eruptions - Excellent
Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - N/A	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Poor	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Fair	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Good	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Excellent
Rey Panettieri, MD: Improving COPD outcomes	Rey Panettieri, MD: Improving COPD outcomes - N/A	Rey Panettieri, MD: Improving COPD outcomes - Poor	Rey Panettieri, MD: Improving COPD outcomes - Fair	Rey Panettieri, MD: Improving COPD outcomes - Good	Rey Panettieri, MD: Improving COPD outcomes - Excellent
Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - N/A	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Poor	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Fair	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Good	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Excellent
Leonard Bacharier, MD: Severe asthma in children	Leonard Bacharier, MD: Severe asthma in children - N/A	Leonard Bacharier, MD: Severe asthma in children - Poor	Leonard Bacharier, MD: Severe asthma in children - Fair	Leonard Bacharier, MD: Severe asthma in children - Good	Leonard Bacharier, MD: Severe asthma in children - Excellent
David Skoner, MD: Update on corticosteroid safety in children	David Skoner, MD: Update on corticosteroid safety in children - N/A	David Skoner, MD: Update on corticosteroid safety in children - Poor	David Skoner, MD: Update on corticosteroid safety in children - Fair	David Skoner, MD: Update on corticosteroid safety in children - Good	David Skoner, MD: Update on corticosteroid safety in children - Excellent
Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - N/A	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Poor	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Fair	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Good	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Excellent
Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - N/A	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Poor	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Fair	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Good	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Excellent
Matt Greenhawt, MD: Food allergy and quality of life	Matt Greenhawt, MD: Food allergy and quality of life - N/A	Matt Greenhawt, MD: Food allergy and quality of life - Poor	Matt Greenhawt, MD: Food allergy and quality of life - Fair	Matt Greenhawt, MD: Food allergy and quality of life - Good	Matt Greenhawt, MD: Food allergy and quality of life - Excellent
David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - N/A	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Poor	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Fair	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Good	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Excellent
Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - N/A	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Poor	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Fair	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Good	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Excellent
David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - N/A	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Poor	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Fair	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Good	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Excellent

Presentation

Speaker was an effective presenter *

Please evaluate the speaker. NOTE: You MUST click N/A if you did not attend a session.

	N/A	Poor	Fair	Good	Excellent
David Lang, MD: Severe asthma: Epidemiology and burden of illness	David Lang, MD: Severe asthma: Epidemiology and burden of illness - N/A	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Poor	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Fair	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Good	David Lang, MD: Severe asthma: Epidemiology and burden of illness - Excellent
Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - N/A	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Poor	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Fair	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Good	Rey Panettieri, Jr., MD: Biomarkers predicting therapeutic response in asthma and COPD - Excellent
Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - N/A	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Poor	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Fair	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Good	Joseph Bellanti, MD: Biologics for severe asthma: Targeting the key cytokines - Excellent
Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD)	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - N/A	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Poor	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Fair	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Good	Mike Wechsler, MD: Eosinophilic lung diseases (other than asthma/COPD) - Excellent
David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - N/A	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Poor	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Fair	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Good	David Lang, MD: Evaluation and management of chronic urticaria/angioedema based on best evidence - Excellent
Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Don Bukstein, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Ray Davis, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Russell Settipane, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - N/A	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Poor	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Fair	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Good	Mike Wechsler, MD: PBL: A 4-year-old girl with moderately severe asthma and history of egg allergy - Excellent
Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - N/A	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Poor	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Fair	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Good	Matt Greenhawt, MD: Utility of component diagnostic testing in food allergy - Excellent
John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - N/A	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Poor	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Fair	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Good	John Bird, MD: Minimizing risk of anaphylaxis and optimizing outcomes in office-based oral food challenge protocols - Excellent
Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - N/A	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Poor	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Fair	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Good	Francisco Bonilla, MD: Intravenous and subcutaneous IgG replacement therapy - Excellent
Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - N/A	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Poor	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Fair	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Good	Jonathan Spergel, MD: Pediatric VS Adult EoE: Similarities and differences in diagnosis and management - Excellent
Alena Banerji, MD: Utility of skin testing in drug allergy	Alena Banerji, MD: Utility of skin testing in drug allergy - N/A	Alena Banerji, MD: Utility of skin testing in drug allergy - Poor	Alena Banerji, MD: Utility of skin testing in drug allergy - Fair	Alena Banerji, MD: Utility of skin testing in drug allergy - Good	Alena Banerji, MD: Utility of skin testing in drug allergy - Excellent
David Khan, MD: Drug induced skin eruptions	David Khan, MD: Drug induced skin eruptions - N/A	David Khan, MD: Drug induced skin eruptions - Poor	David Khan, MD: Drug induced skin eruptions - Fair	David Khan, MD: Drug induced skin eruptions - Good	David Khan, MD: Drug induced skin eruptions - Excellent
Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - N/A	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Poor	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Fair	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Good	Mike Wechsler, MD: The epidemiology and clinical significance of eosinophilia in asthma and COPD - Excellent
Rey Panettieri, MD: Improving COPD outcomes	Rey Panettieri, MD: Improving COPD outcomes - N/A	Rey Panettieri, MD: Improving COPD outcomes - Poor	Rey Panettieri, MD: Improving COPD outcomes - Fair	Rey Panettieri, MD: Improving COPD outcomes - Good	Rey Panettieri, MD: Improving COPD outcomes - Excellent
Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Russell Settipane, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - N/A	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Poor	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Fair	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Good	Mike Wechsler, MD: PBL: A 12-year-old boy living in the inner city with difficult to control asthma - Excellent
Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - N/A	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Poor	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Fair	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Good	Stanley Szefler, MD: Examining causes of the urban (inner-city) asthma epidemic - Excellent
Leonard Bacharier, MD: Severe asthma in children	Leonard Bacharier, MD: Severe asthma in children - N/A	Leonard Bacharier, MD: Severe asthma in children - Poor	Leonard Bacharier, MD: Severe asthma in children - Fair	Leonard Bacharier, MD: Severe asthma in children - Good	Leonard Bacharier, MD: Severe asthma in children - Excellent
David Skoner, MD: Update on corticosteroid safety in children	David Skoner, MD: Update on corticosteroid safety in children - N/A	David Skoner, MD: Update on corticosteroid safety in children - Poor	David Skoner, MD: Update on corticosteroid safety in children - Fair	David Skoner, MD: Update on corticosteroid safety in children - Good	David Skoner, MD: Update on corticosteroid safety in children - Excellent
Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - N/A	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Poor	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Fair	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Good	Francisco Bonilla, MD: Update on testing for primary immunodeficiency disease - Excellent
Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - N/A	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Poor	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Fair	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Good	Alena Banerji, MD: HAE: Special consideration in children, women of childbearing age and the elderly - Excellent
Matt Greenhawt, MD: Food allergy and quality of life	Matt Greenhawt, MD: Food allergy and quality of life - N/A	Matt Greenhawt, MD: Food allergy and quality of life - Poor	Matt Greenhawt, MD: Food allergy and quality of life - Fair	Matt Greenhawt, MD: Food allergy and quality of life - Good	Matt Greenhawt, MD: Food allergy and quality of life - Excellent
David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - N/A	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Poor	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Fair	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Good	David Khan, MD: Safety of allergy immunotherapy: SLIT VS SCIT - Excellent
Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - N/A	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Poor	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Fair	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Good	Linda Cox, MD - CON: Debate: SLIT is effective in polysensitized individuals - Excellent
David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - N/A	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Poor	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Fair	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Good	David Skoner, MD - Pro: Debate: SLIT is effective in polysensitizied individuals - Excellent

Did any of the speakers have commercial bias? *

Yes

Please provide more detail about the bias observed *

Did the speaker(s) properly disclose relevant financial relationships (name of commercial interest and nature of the relationship) or state that they had nothing to disclose? *

Yes

Please explain *

Was any off-label (investigational/experimental) use discussed? *

Yes

Was this disclosed to the learners? *

Yes

Please identify the speaker and explain *

Based on the content of this session/activity, what will you do differently in the care of your patients? *

Implement a change in my practice

Seek additional information on this topic

Do nothing differently. Current practice reflects activity recommendations.

Do nothing differently as the content was not convincing.

Do nothing differently; system barriers prevent me from changing my practice.

Not applicable. I do not see patients with the condition discussed or I do not see patients in my current position.

Please describe what changes you plan to implement *

Please indicate the primary system barriers preventing change *

Lack of evidence-based guidelines

Lack of applicability of guidelines to my current practice/patients

Lack of time

Insurance/Financial

Organizational/Institutional

Patient adherence/Compliance

Treatment related to adverse events

Not applicable. I don't see patients with the condition discussed or I don't see patients in my current position.

Other...

Please indicate the primary system barriers preventing change Other...

Based on educational needs, please provide healthcare or professional gaps that should be addressed in future educational activities and that may be applicable to your practice

Leave this field blank

College Learning Connection - Allergy & Asthma Education Programs

EAC 2015 Update in Allergy, Asthma and Immunology

Evaluation

Evaluation

Claim Credit

Certificate

Course navigation

Search form

You are here

EAC 2015 Update in Allergy, Asthma and Immunology

Evaluation

Evaluation

Claim Credit

Certificate

Course navigation